| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |